1. Home
  2. YDESW

as 11-25-2025 3:42pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Nasdaq

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Founded: N/A Country:
United States
United States
Employees: N/A City: N/A
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest YD Bio Limited Warrants News

YDESW Breaking Stock News: Dive into YDESW Ticker-Specific Updates for Smart Investing

All YDESW News

Share on Social Networks: